Onasemnogene Abeparvovec-xioi: Gene Therapy for Spinal Muscular Atrophy
Abstract
Objective: To review the efficacy and safety of onasemnogene abeparvovec-xioi (Zolgensma) in the treatment of spinal muscular atrophy (SMA). Data Sources: An English-language literature search of PubMed, MEDLINE, and Ovid (1946 to December 2019) was completed using the terms onasemnogene, AVXS-101, and spinal muscular atrophy. Manufacturer prescribing information, article bibliographies, and data from ClinicalTrials.gov were incorporated in the...
Paper Details
Title
Onasemnogene Abeparvovec-xioi: Gene Therapy for Spinal Muscular Atrophy
Published Date
Mar 23, 2020
Journal
Volume
54
Issue
10
Pages
1001 - 1009
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History